Shingles vaccination in immune-mediated inflammatory diseases: a narrative review

Lara D. Veeken 2026 Open access

Read full text
Authors: Rajiv Ark, Victoria Allen, Katie Bechman, Zijing Yang, Deepak Nagra, Mark Russell, James Galloway
DOI: 10.1093/rheumatology/keag043
Cited by: 1
References: 52

Abstract

There are several pressing reasons to re-examine shingles and strategies for its prevention through vaccination. Firstly, the UK has recently recommended the introduction of a national childhood varicella vaccination programme, and this may impact the epidemiology of shingles. Secondly, treatments for immune-mediated inflammatory diseases are increasingly targeting immunological pathways essential for antiviral defence. Thirdly, we now have access to a highly efficacious shingles vaccine. This review article will explore each of these developments in a way that is globally relevant, incorporating international recommendations.

Fields of Study & Subjects

Herpesvirus Infections and Treatments Virology and Viral Diseases Poxvirus research and outbreaks

Publication details

Journal / source
Lara D. Veeken
Publisher
Oxford University Press (OUP)
Volume
65
Issue
2
Publication date
22 January 2026
Language
EN